Cancer Control & Psychoneuroimmunology Lab

Welcome to the Cancer Control and Psychoneuroimmunology Lab

The Cancer Control and Psychoneuroimmunology Laboratory (CCPL), led by Dr. Michelle Janelsins, is a clinical and translational research lab that is focused on three main project areas from T1-T4 levels of research:

Understanding clinical, psychological, and biological mechanisms of cognitive difficulties in cancer patients
Investigating interventions to alleviate cognitive difficulties in cancer patients
Translational models of cognitive difficulties in cancer

We use a number of multidisciplinary approaches in psychoneuroimmunology, immunology, neuroscience and cognitive science spanning from basic research in animal model and cell culture systems to large cohort studies and randomized clinical trials.

Michelle C. Janelsins-Benton, Ph.D.
Principal Investigator

Research Projects

Lab Members

Collaborators

Policies & Procedures & Equipment

Research Projects

Characterization of cancer-related cognitive impairment in cancer patients and the psychoneuroimmunological impact of cancer treatments on cognitive function

Randomized clinical trials of the effects of exercise and anti-inflammatories on cognitive function in cancer patients

Translational mouse models of cancer-related cognitive impairment

View All Projects

Recent Publications

1. Gilmore N
2. Xu H
3. Kehoe L
4. Kleckner AS
5. Moorthi K
6. Lei L
7. Mohamed MRS
8. Loh KPM
9. Culakova E
10. Flannery M
11. Ramsdale E
12. Duberstein PR
13. Canin B
14. Kamen C
15. Giri G
16. Watson E
17. Patil A
18. Onitilo AA
19. Burnette B
20. Janelsins M
21. Mohile SG
Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists.; Cancer. 2021 Nov 11.
1. Mohile SG
2. Mohamed MR
3. Xu H
4. Culakova E
5. Loh KP
6. Magnuson A
7. Flannery MA
8. Obrecht S
9. Gilmore N
10. Ramsdale E
11. Dunne RF
12. Wildes T
13. Plumb S
14. Patil A
15. Wells M
16. Lowenstein L
17. Janelsins M
18. Mustian K
19. Hopkins JO
20. Berenberg J
21. Anthony N
22. Dale W
Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.; Lancet (London, England). 2021 Nov 03.
1. Salerno EA
2. Culakova E
3. Kleckner AS
4. Heckler CE
5. Lin PJ
6. Matthews CE
7. Conlin A
8. Weiselberg L
9. Mitchell J
10. Mustian KM
11. Janelsins MC
Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Aug 18.

View All Publications

Affiliations

Surgery

News

Dr. Michelle Janelsins Awarded Highest Honor for Young Investigators - WXXI News
Dr. Michelle Janelsins Earns Exceptional Investigator Award to Study Chemo-Brain - URMC Newsroom
Dr. Michelle Janelsins NPR Interview - NPR News
Dr. Michelle Janelsins receives Outstanding Young Investigator Award - Multinational Association of Supportive Care in Cancer (MASCC)

Contact Us

Cancer Control & Psychoneuroimmunology Lab
601 Elmwood Ave
Rochester, NY 14642

Michelle_Janelsins@urmc.rochester.edu

(585) 273-1940

Clinical Research:
Kassandra Doyle, B.S.
Clinical Research Coordinator

(585) 276-7142

Basic Research:
Bryan Thompson, B.S.
Technical Associate I

(585) 273-1940